1 Jun 2026Open access
Pneumothorax detection using a learning focal point architecturePublisher siteIAES International Journal of Artificial Intelligence, Lung Cancer Diagnosis and Treatment
UniversitiesBouabid Qabliyane
Active, last published 2026
In lung cancer diagnosis and treatment
Bouabid
Qabliyane
Scholar“Research focused on Lung Cancer Diagnosis and Treatment and adjacent fields.”
Université Sultan Moulay Slimane
Claim Your Profile0
H-index
0
Citations
Bouabid has not officially claimed their profile. If you are Bouabid, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ouabid Qabliyane is a researcher working on Lung Cancer Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Bouabid's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Lung Cancer Diagnosis and Treatment×1Medical Image Segmentation Techniques×1COVID-19 diagnosis using AI×1
04 · Where I am
Affiliations
Affiliation on published researchUniversité Sultan Moulay SlimaneDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works17 Apr 2026Open access
Supervised Machine Learning-Based Multiclass Classification and Interpretable Feature Importance Analysis of Teacher Job SatisfactionPublisher siteInformation, AI and HR Technologies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Bouabid?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you